|
業務類別
|
Biotechnology |
|
業務概覽
|
Telix is a developer of radiopharmaceuticals. Radiopharmaceuticals are specialized drugs containing radioactive isotopes, which are used in both diagnosing and treating cancer. At low doses, these drugs bind to a specific cancer cell and can be visualized through PET imaging. With high doses, they can deliver targeted treatment. Telix has a pipeline of both diagnostics and therapeutics in development. Its pipeline is focused on urologic oncology (prostate, kidney and bladder), neuro-oncology (glioma), musculoskeletal oncology and hematology. Currently, most of the firm's revenue comes from its Illuccix prostate cancer imaging/diagnostic agent. |
| 公司地址
| 55 Flemington Road, Level 4, North Melbourne, Melbourne, VIC, AUS, 3051 |
| 電話號碼
| +61 390933855 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.telixpharma.com |
| 員工數量
| 1184 |
| Dr. Christian Behrenbruch, M.B.A.,PhD |
Director, Managing Director and Group Chief Executive Officer |
美元 556.72K |
20/02/2026 |
| Mr. Darren Patti, Pharm.D. |
Group Chief Operating Officer |
美元 381.88K |
20/02/2026 |
| Mr. Darren Smith, M.B.A. |
Group Chief Financial Officer |
美元 488.99K |
20/02/2026 |
| Mr. David Cade, M.B.A.,M.D. |
Group Chief Medical Officer |
美元 368.90K |
20/02/2026 |
| Mr. Kevin Richardson |
Chief Executive Officer, Telix Precision Medicine |
-- |
20/02/2026 |
| Dr. Mary Jessel |
Group Chief of Clinical Affairs |
-- |
20/02/2026 |
| Mr. Richard Valeix |
Chief Executive Officer, Telix Therapeutics |
美元 255.26K |
20/02/2026 |
| Ms. Lena Moran-Adams |
Group General Counsel |
-- |
20/02/2026 |
| Ms. Meredith Crowe |
Senior Vice President, People and Culture |
-- |
20/02/2026 |
| Ms. Genevieve Ryan |
Company Secretary |
-- |
20/02/2026 |
| Mr. Raphael Ortiz |
Chief Executive Officer, Telix International |
-- |
20/02/2026 |
|
|
| Ms. Marie McDonald |
Independent Director |
20/02/2026 |
| Dr. Christian Behrenbruch, M.B.A.,PhD |
Director, Managing Director and Group Chief Executive Officer |
20/02/2026 |
| Dr. Mark Nelson, M.Phil,PhD |
Interim Chairman of the board |
20/02/2026 |
| Ms. Jann Skinner, B.Com,F.C.A. |
Independent Director |
20/02/2026 |
|
|
|
|